117 related articles for article (PubMed ID: 35176860)
1. New Class of Drug Modalities: Directed Evolution of a De Novo Designed Helix-Loop-Helix Peptide to Bind VEGF for Tumor Growth Inhibition.
Michigami M; Ramanayake Mudiyanselage TMR; Suzuki M; Ishizako H; Notsu K; Sugiura K; Fujii I
ACS Chem Biol; 2022 Mar; 17(3):647-653. PubMed ID: 35176860
[TBL] [Abstract][Full Text] [Related]
2. A "ligand-targeting" peptide-drug conjugate: Targeted intracellular drug delivery by VEGF-binding helix-loop-helix peptides via receptor-mediated endocytosis.
Michigami M; Takahashi K; Yamashita H; Ye Z; Nakase I; Fujii I
PLoS One; 2021; 16(2):e0247045. PubMed ID: 33630870
[TBL] [Abstract][Full Text] [Related]
3. An Immune-Stimulatory Helix-Loop-Helix Peptide: Selective Inhibition of CTLA-4-B7 Interaction.
Ramanayake Mudiyanselage TMR; Michigami M; Ye Z; Uyeda A; Inoue N; Sugiura K; Fujii I; Fujiwara D
ACS Chem Biol; 2020 Feb; 15(2):360-368. PubMed ID: 31841301
[TBL] [Abstract][Full Text] [Related]
4. Chemical Modification of Phage-Displayed Helix-Loop-Helix Peptides to Construct Kinase-Focused Libraries.
Fujiwara D; Mihara K; Takayama R; Nakamura Y; Ueda M; Tsumuraya T; Fujii I
Chembiochem; 2021 Dec; 22(24):3406-3409. PubMed ID: 34605137
[TBL] [Abstract][Full Text] [Related]
5. Conformationally Constrained Peptides with High Affinity to the Vascular Endothelial Growth Factor.
Guryanov I; Korzhikov-Vlakh V; Bhattacharya M; Biondi B; Masiero G; Formaggio F; Tennikova T; Urtti A
J Med Chem; 2021 Aug; 64(15):10900-10907. PubMed ID: 34269584
[TBL] [Abstract][Full Text] [Related]
6. Selection of inhibitory peptides for Aurora-A kinase from a phage-displayed library of helix-loop-helix peptides.
Fujiwara D; Ye Z; Gouda M; Yokota K; Tsumuraya T; Fujii I
Bioorg Med Chem Lett; 2010 Mar; 20(5):1776-8. PubMed ID: 20117931
[TBL] [Abstract][Full Text] [Related]
7. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
[TBL] [Abstract][Full Text] [Related]
8. A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library.
El-Mousawi M; Tchistiakova L; Yurchenko L; Pietrzynski G; Moreno M; Stanimirovic D; Ahmad D; Alakhov V
J Biol Chem; 2003 Nov; 278(47):46681-91. PubMed ID: 12954624
[TBL] [Abstract][Full Text] [Related]
9. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
Lu D; Shen J; Vil MD; Zhang H; Jimenez X; Bohlen P; Witte L; Zhu Z
J Biol Chem; 2003 Oct; 278(44):43496-507. PubMed ID: 12917408
[TBL] [Abstract][Full Text] [Related]
10. Disrupting VEGF-VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF
Balsera B; Bonache MÁ; Reille-Seroussi M; Gagey-Eilstein N; Vidal M; González-Muñiz R; Pérez de Vega MJ
Molecules; 2017 Oct; 22(11):. PubMed ID: 29143774
[TBL] [Abstract][Full Text] [Related]
11. A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis.
Farzaneh Behelgardi M; Zahri S; Mashayekhi F; Mansouri K; Asghari SM
Sci Rep; 2018 Dec; 8(1):17924. PubMed ID: 30560942
[TBL] [Abstract][Full Text] [Related]
12. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S
J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
Baek DS; Kim JH; Kim YJ; Kim YS
Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
[TBL] [Abstract][Full Text] [Related]
14. Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling.
Haase HS; Peterson-Kaufman KJ; Lan Levengood SK; Checco JW; Murphy WL; Gellman SH
J Am Chem Soc; 2012 May; 134(18):7652-5. PubMed ID: 22548447
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
Zhu Z; Hattori K; Zhang H; Jimenez X; Ludwig DL; Dias S; Kussie P; Koo H; Kim HJ; Lu D; Liu M; Tejada R; Friedrich M; Bohlen P; Witte L; Rafii S
Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950
[TBL] [Abstract][Full Text] [Related]
16. Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis.
Bae DG; Gho YS; Yoon WH; Chae CB
J Biol Chem; 2000 May; 275(18):13588-96. PubMed ID: 10788475
[TBL] [Abstract][Full Text] [Related]
17. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
[TBL] [Abstract][Full Text] [Related]
18. Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.
Checco JW; Kreitler DF; Thomas NC; Belair DG; Rettko NJ; Murphy WL; Forest KT; Gellman SH
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4552-7. PubMed ID: 25825775
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class.
Gille H; Hülsmeyer M; Trentmann S; Matschiner G; Christian HJ; Meyer T; Amirkhosravi A; Audoly LP; Hohlbaum AM; Skerra A
Angiogenesis; 2016 Jan; 19(1):79-94. PubMed ID: 26650228
[TBL] [Abstract][Full Text] [Related]
20. Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide.
D'Andrea LD; Iaccarino G; Fattorusso R; Sorriento D; Carannante C; Capasso D; Trimarco B; Pedone C
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14215-20. PubMed ID: 16186493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
